Cerebral palsy in children born after in vitro fertilization. Is the risk decreasing?

A J Bengt Källén1, O Orvar Finnström, Anna P Lindam

  • 1Tornblad Institute, University of Lund, Biskopsgatan 7, SE-223 62 Lund, Sweden. bengt.kallen@med.lu.se

Insights

Children conceived via in vitro fertilization (IVF) have a slightly increased risk for cerebral palsy (CP). This risk is primarily linked to multiple births and neonatal complications, not the IVF procedure itself.

Area of Science:

  • Reproductive Medicine
  • Pediatric Neurology
  • Public Health

Background:

  • Infants conceived via in vitro fertilization (IVF) present unique characteristics compared to spontaneously conceived infants.
  • These characteristics, including higher rates of multiple births, preterm delivery, and neonatal complications, may elevate the risk of cerebral palsy (CP).

Purpose of the Study:

  • To investigate the long-term risk of cerebral palsy (CP) in children conceived through in vitro fertilization (IVF).

Main Methods:

  • A cohort study identified infants born after IVF in Sweden (1982-2007) using data from IVF clinics.
  • Perinatal data were linked with the Swedish Medical Birth Register.
  • Cerebral palsy diagnoses were identified through the Patient Register, with statistical adjustments for confounding factors like birth year, maternal age, parity, and smoking.

Main Results:

  • The adjusted odds ratio for CP in IVF-conceived children was 1.81, but this risk was not statistically significant when analyzed for singletons or unlike-sexed twins.
  • Stratification by neonatal outcomes also reduced the odds ratios to non-significant levels.
  • In recent years (2004-2007) with reduced twinning rates (<10%), the odds ratio for CP approached 1 (0.97), indicating no significant increase.

Conclusions:

  • The observed moderate increase in cerebral palsy risk among IVF-conceived children is likely attributable to increased neonatal morbidity, particularly associated with multiple births.
  • The findings suggest that as IVF practices evolve to reduce multiple gestations, the associated risk of CP may diminish.
Abstract

Related Concept Videos

In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...